eConsent

Clinical ink eConsent is a digital informed consent solution designed for clinical trials, helping sponsors, study teams, and sites improve patient enrollment, comprehension, and retention. As part of the broader Clinical ink eSource technology platform, eConsent simplifies and standardizes the consent process through an intuitive, patient-friendly interface that guides participants and caregivers from initial education through to digital signature and ongoing re-consent.

The platform is built for clinical research organizations and site teams seeking to reduce administrative burden, accelerate study startup, and maintain rigorous regulatory compliance. By replacing paper-based consent with a dynamic digital experience, Clinical ink eConsent enhances data quality, supports decision-making, and ensures traceability throughout the life of a study.

Patient Experience and Engagement

• Delivers easy-to-follow, patient-friendly eConsent forms with tiered information presentation and knowledge checks to verify comprehension.
• Supports graphical and video content to make complex trial information more accessible and digestible.
• Provides translation into 40+ native languages, broadening accessibility for diverse participant populations.
• Allows participants to review materials at their own pace, ask questions, and make informed decisions with confidence.
• Incorporates a patient-centered approach that improves trust, satisfaction, and overall engagement with the trial.

Consent Process and Compliance

• Ensures eConsent compliancy through real-time triggers, automated notifications, progress metrics, and detailed reporting.
• Supports reconsenting triggers to keep participants up to date when protocol changes occur.
• Integrates signature requirements to ensure clinicians and participants meet FDA 21 CFR Part 11 compliance standards.
• Adheres to HIPAA regulations and employs encryption methods to protect participant personal data.
• Digital signatures and timestamps provide secure, verifiable consent tracking that facilitates easier auditing.

Site and Study Team Efficiency

• Manages end-to-end eConsent and re-consent processes from a single platform, reducing complexity for site staff.
• Enables monitoring of patient interactions in real time, ensuring participants are always current on protocol updates.
• Provides real-time patient snapshots, allowing teams to quickly access and monitor the status of individual trial participants.
• Enhances workflows with dynamic visit creation and conditional logic across clinical trial processes.
• Minimizes errors throughout the consent process, contributing to improved overall data quality.

Study Startup and Cost Savings

• Accelerates study startup timelines from months to weeks using drag-and-drop authoring tools and rapid prototyping capabilities.
• Reduces strain on study teams and sites while lowering overall operational costs.
• Eliminates the need for separate systems by integrating directly with Clinical ink eSource technology, including DDC, ePRO, and eCOA modules.
• Simplifies end-to-end data capture processes through a unified, connected platform.

Integration and Workflow Customization

• Designed for seamless integration into existing clinical trial workflows, with flexibility and customization to align with specific study requirements.
• Clinical ink works closely with study teams to ensure a smooth transition to digital consent, providing training and support as needed.
• Supports conditional logic and dynamic visit creation to adapt consent workflows to the unique demands of each protocol.

Clinical ink eConsent is a fully compliant, enterprise-ready solution that integrates within the Clinical ink eSource ecosystem. It supports regulatory requirements including FDA 21 CFR Part 11 and HIPAA, and is suitable for global studies requiring multilingual support and robust data security measures.